COPD8USA: A Multi-Disciplinary Clinical and Scientific Conference

描述（由申请人提供）：慢性阻塞性肺疾病（COPD）是一种流行的、逐渐衰弱的健康状况，在美国影响超过1200万确诊患者和估计1200万未确诊患者。COPD造成约140，000人死亡，每年花费高达500亿美元。与其他主要死亡原因不同，COPD持续上升，2008年成为美国第三大死亡原因。患有COPD的个体可能花费数年未被发现，即使正确诊断，个体也经常接受不一致的护理，这些护理不遵循循证实践，不考虑多种复杂的共病状况或在团队方法中实践以患者为中心的原则。公共和私人研究投资取得了巨大的进步，但研究表明，许多患者并没有从这些进步中受益，而且仍然存在巨大的研究差距。临床护理团队往往缺乏对新疗法的充分培训，并且在孤岛上工作，这妨碍了适当的护理协调，并在从工作台到床边的转变中造成更大的障碍。国家心肺血液研究所（NHLBI）致力于COPD基础研究的需求，并与临床和患者社区建立联系，以确保改善公共卫生状况。NHLBI对COPD遗传流行病学项目、Spiromics和NETT的资助得到了对COPD的投资的补充：了解更多Breathe Better Campaign及其对机构间合作伙伴关系的承诺，以推进美国COPD的流行病学研究。为了满足对教育和研究论坛的需求，以促进仅关注COPD的公共和私人多学科交流，COPD基金会与国际专家Robert Stockley和Sue Hill合作，使成功的欧洲COPD会议系列适应美国的具体需求。COPD 8 USA是美国系列的第二届，将于2013年6月13日至15日在伊利诺伊州芝加哥与COPD会前峰会和COPD社区教育研讨会的再入院一起召开。内布拉斯加大学医学中心继续教育中心（UNMC-CCE）将作为COPD 8 USA的认证提供商。COPD 8 USA的总体目标是激励政府、临床、研究和患者社区制定一种协调和全面的方法，以改善研究、临床护理、护理提供协调和其他公共卫生干预措施的知识和实施，这些措施对扭转COPD日益加重的负担至关重要。COPD 8 USA的参与者和教师代表了临床护理团队，学术研究人员，医院管理人员和护理协调员，政府和私人政策制定者以及受疾病影响的患者和护理人员的整个范围。COPD 8 USA提供了一个独特的论坛，以促进COPD专家和与会者（包括年轻研究人员）之间的学习和互动。

DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) is a prevalent; progressively debilitating health condition that affects over 12 million diagnosed and an estimated 12 million more undiagnosed individuals in the U.S. COPD is responsible for approximately 140,000 deaths and costs upwards of 50 billion annually. Unlike other leading causes of death, COPD continues to rise and in 2008, it became the 3rd leading cause of death in the US. Individuals with COPD may spend years undetected and even when diagnosed properly, individuals often receive inconsistent care that does not follow evidence based practices, account for the multiple complex comorbid conditions or practice patient centered principles in a team approach. Public and private research investment has yielded great advances, yet studies show many patients do not benefits from these advances and large research gaps remain. The clinical care team often lacks sufficient training on new therapies and work in silos, preventing proper care coordination and causing even greater barriers in translating from the bench to bedside. The National Heart, Lung and Blood Institute (NHLBI) have shown dedication to the need for basic research in COPD, and to making the connections to the clinical and patient communities to ensure improvements to public health status. The NHLBI's funding for the Genetic Epidemiology of COPD project, Spiromics and NETT are complimented by its investment in the COPD: Learn More Breathe Better Campaign and its commitment to inter-agency partnerships to advance the epidemiological study of COPD in the U.S. To meet the need for a education and research forum to advance public and private, multi-disciplinary communication solely focused on COPD, the COPD Foundation partnered with international experts Robert Stockley and Sue Hill to adapt the successful European COPD Conferences Series to US specific needs. COPD8USA is the second in the US series and will be convened alongside the Readmissions in COPD Pre-Conference Summit and the COPD Community Education Workshop from June 13-15, 2013 in Chicago, IL. The University of Nebraska Medical Center, Center for Continuing Education (UNMC-CCE) will serve as the accredited provider for COPD8USA. The overall objective of COPD8USA is to stimulate the government, clinical, research and patient communities to create a coordinated and comprehensive approach for improvements in the knowledge and implementation of research, clinical care, care delivery coordination and other public health interventions critical to reversig the growing burden of COPD. COPD8USA participants and faculty represent the entire spectrum of clinical care teams, academic researchers, hospital administrators and care coordinators, government and private policy makers and patients and caregivers that are affected by the disease. COPD8USA offers a unique forum to foster learning and interactions between COPD experts and conference attendees, including young investigators.